Frontiers in Medicine (Jan 2022)

Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma

  • Daniel C. Osei-Bordom,
  • Daniel C. Osei-Bordom,
  • Daniel C. Osei-Bordom,
  • Gagandeep Sachdeva,
  • Niki Christou,
  • Niki Christou,
  • Niki Christou

DOI
https://doi.org/10.3389/fmed.2021.788869
Journal volume & issue
Vol. 8

Abstract

Read online

Pancreatic ductal adenocarcinomas (PDAC) represent one of the deadliest cancers worldwide. Survival is still low due to diagnosis at an advanced stage and resistance to treatment. Herein, we review the main types of liquid biopsy able to help in both prognosis and adaptation of treatments.

Keywords